- Home
- BEAT vs TBHC Comparison
BEAT vs TBHC Comparison
Compare BEAT & TBHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAT
- TBHC
- Stock Information
- Founded
- BEAT 2015
- TBHC 1966
- Country
- BEAT United States
- TBHC United States
- Employees
- BEAT N/A
- TBHC N/A
- Industry
- BEAT Retail: Computer Software & Peripheral Equipment
- TBHC Other Specialty Stores
- Sector
- BEAT Technology
- TBHC Consumer Discretionary
- Exchange
- BEAT Nasdaq
- TBHC Nasdaq
- Market Cap
- BEAT 33.1M
- TBHC 27.6M
- IPO Year
- BEAT 2021
- TBHC N/A
- Fundamental
- Price
- BEAT $1.03
- TBHC $1.49
- Analyst Decision
- BEAT Buy
- TBHC
- Analyst Count
- BEAT 1
- TBHC 0
- Target Price
- BEAT $8.00
- TBHC N/A
- AVG Volume (30 Days)
- BEAT 118.9K
- TBHC 370.8K
- Earning Date
- BEAT 08-13-2025
- TBHC 09-04-2025
- Dividend Yield
- BEAT N/A
- TBHC N/A
- EPS Growth
- BEAT N/A
- TBHC N/A
- EPS
- BEAT N/A
- TBHC N/A
- Revenue
- BEAT N/A
- TBHC $431,111,000.00
- Revenue This Year
- BEAT N/A
- TBHC N/A
- Revenue Next Year
- BEAT N/A
- TBHC N/A
- P/E Ratio
- BEAT N/A
- TBHC N/A
- Revenue Growth
- BEAT N/A
- TBHC N/A
- 52 Week Low
- BEAT $0.91
- TBHC $1.20
- 52 Week High
- BEAT $3.48
- TBHC $1.73
- Technical
- Relative Strength Index (RSI)
- BEAT 40.15
- TBHC N/A
- Support Level
- BEAT $0.91
- TBHC N/A
- Resistance Level
- BEAT $1.32
- TBHC N/A
- Average True Range (ATR)
- BEAT 0.12
- TBHC 0.00
- MACD
- BEAT 0.01
- TBHC 0.00
- Stochastic Oscillator
- BEAT 29.27
- TBHC 0.00
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.